…amazing how much progress made in these back of the eye diseases over past 15 yrs.
When you posted this in Feb 2018, I initially thought you were being sarcastic because there hasn’t been a lot of improvement in treating back-of-the-eye diseases since the 2006 approval of Lucentis.
Maybe bi-specifics will be the ticket.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”